Keywords: Xenon Pharma, Roche, Genentech, Pain therapies, Diagnostics

Xenon in $646 million deal with Roche unit

Article | 10 January 2012

Canada based Xenon Pharmaceuticals, a privately-owned, clinical genetics-based drug discovery and development company, has entered into a strategic alliance with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Genentech

Xenon Pharmaceuticals

Go to company listing